1Life Healthcare, Inc. (NASDAQ:ONEM) Shares Sold by Tudor Investment Corp Et Al

Posted by on Mar 8th, 2023

Tudor Investment Corp Et Al decreased its holdings in shares of 1Life Healthcare, Inc. (NASDAQ:ONEM – Get Rating) by 82.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,429 shares of the company’s stock after selling 105,306 shares during the quarter. Tudor Investment Corp Et Al’s holdings in 1Life Healthcare were worth $385,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of 1Life Healthcare by 2.3% during the 1st quarter. Vanguard Group Inc. now owns 14,448,803 shares of the company’s stock valued at $160,092,000 after acquiring an additional 324,722 shares in the last quarter. Alpine Associates Management Inc. purchased a new stake in 1Life Healthcare during the 3rd quarter worth $86,447,000. State Street Corp increased its stake in 1Life Healthcare by 35.4% during the 2nd quarter. State Street Corp now owns 3,685,942 shares of the company’s stock worth $28,898,000 after buying an additional 964,549 shares during the period. Millennium Management LLC increased its stake in 1Life Healthcare by 47.6% during the 2nd quarter. Millennium Management LLC now owns 3,551,659 shares of the company’s stock worth $27,845,000 after buying an additional 1,145,722 shares during the period. Finally, Sand Grove Capital Management LLP purchased a new stake in 1Life Healthcare during the 3rd quarter worth $54,226,000. Institutional investors and hedge funds own 78.20% of the company’s stock.

1Life Healthcare Stock Performance

1Life Healthcare stock opened at $16.47 on Wednesday. 1Life Healthcare, Inc. has a 12-month low of $5.94 and a 12-month high of $17.55. The company has a market capitalization of $3.37 billion, a price-to-earnings ratio of -8.19 and a beta of 1.99. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.09 and a quick ratio of 2.06. The firm’s fifty day moving average price is $16.12 and its 200 day moving average price is $16.69.

1Life Healthcare (NASDAQ:ONEM – Get Rating) last released its quarterly earnings results on Tuesday, February 21st. The company reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.52) by $0.03. 1Life Healthcare had a negative net margin of 38.05% and a negative return on equity of 24.58%. The firm had revenue of $274.24 million for the quarter, compared to the consensus estimate of $276.10 million. During the same quarter in the previous year, the firm posted ($0.50) EPS. The firm’s quarterly revenue was up 19.1% on a year-over-year basis. On average, research analysts forecast that 1Life Healthcare, Inc. will post -1.8 EPS for the current fiscal year.

Insider Transactions at 1Life Healthcare

In other news, CAO Vikas Agarwal sold 2,117 shares of the business’s stock in a transaction dated Thursday, February 16th. The shares were sold at an average price of $15.36, for a total value of $32,517.12. Following the completion of the sale, the chief accounting officer now owns 8,866 shares of the company’s stock, valued at approximately $136,181.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Vikas Agarwal sold 2,117 shares of the business’s stock in a transaction dated Thursday, February 16th. The shares were sold at an average price of $15.36, for a total value of $32,517.12. Following the completion of the sale, the chief accounting officer now owns 8,866 shares of the company’s stock, valued at approximately $136,181.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Bjorn B. Thaler sold 6,015 shares of the business’s stock in a transaction dated Thursday, February 16th. The stock was sold at an average price of $15.36, for a total transaction of $92,390.40. Following the completion of the sale, the chief financial officer now directly owns 21,532 shares of the company’s stock, valued at approximately $330,731.52. The disclosure for this sale can be found here. In the last 90 days, insiders sold 21,844 shares of company stock valued at $343,842. Insiders own 4.40% of the company’s stock.

About 1Life Healthcare

(Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

Featured Stories

Institutional Ownership by Quarter for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.